查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2088488

腎臟病治療醫療設備市場：按產品類型、方式、應用和最終用戶分類的全球市場預測 – 2026-2032 年

Nephrology Devices Market by Product Type, Modality, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，用於治療腎臟疾病的醫療設備市場將成長至 219.4 億美元，複合年成長率為 6.50%。

主要市場統計數據
基準年 2025 141.1億美元
預計年份：2026年 150億美元
預測年份 2032 219.4億美元
複合年成長率 (%) 6.50%

腎臟疾病治療醫療設備執行摘要

用於治療腎臟疾病的醫療設備正逐漸成為慢性腎臟病、急性腎損傷、透析、腎結石和腎臟替代療法管理的核心支柱。這種需求是結構性的。同行評審的估計表明，全球有超過8億人患有慢性腎臟病，而世界衛生組織的數據則指出，糖尿病和高血壓是腎衰竭的主要上游危險因子。

腎臟病治療醫療設備市場發生變革性變化

用於治療腎臟疾病的醫療設備市場趨勢正從以診所為中心的透析系統轉向早期療育、居家腎臟護理和數位整合治療模式。 「改善全球腎臟病預後組織（KDIGO）」指南繼續強調風險分層、蛋白尿尿液檢查、血壓管理、糖尿病管理以及以患者為中心的治療選擇，從而導致對支持長期腎臟護理的醫療設備的需求不斷成長。

人工智慧對腎病醫療設備的累積影響

人工智慧 (AI) 透過改善病患監測、治療計劃、預測性維護和臨床工作流程，正對腎臟疾病醫療設備產生整體累積的影響。儘管美國食品藥物管理局 (FDA) 和其他監管機構對人工智慧驅動的醫療技術保持積極的監管，但醫療系統正在使用檢驗的分析方法來識別急性腎損傷的風險、預警透析併發症並支援協調護理。

全球腎臟疾病醫療設備市場主要區域趨勢

在亞太地區，受糖尿病高發生率、人口老化和透析基礎設施不斷完善的推動，腎臟醫療設備在中國、印度、日本、韓國和澳洲的應用正在不斷擴展。日本和韓國擁有成熟的透析品管體系，而中國和印度正在擴大醫院容量、公共醫療覆蓋範圍並發展本地醫療設備生產。在澳大利亞，遠距醫療和居家透析模式正在推廣，互聯監測和服務可靠性至關重要。

關於東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵群體特定見解

東協地區，特別是印尼、泰國、馬來西亞、越南和菲律賓的需求，受到全民健康覆蓋（UHC）計劃的擴展、都市區透析網路的發展以及糖尿病負擔日益加重等因素的影響。該地區需要經濟實惠的血液透析機、可靠的耗材、培訓以及可擴展的腹膜透析方案，以改善主要城市以外地區的醫療服務。海灣合作理事會（GCC）國家正優先發展先進的醫院基礎設施、進口專用醫療設備、建造本地腎臟護理體係以及公私合營，以減少對海外治療的依賴。

針對主要腎病醫療設備市場的國家/地區特定洞察

美國在透析支出、監管透明度、全國性末期腎功能衰竭（ESRD）數據基礎設施以及居家照護政策的推進方面處於主導，而加拿大則強調省級報銷制度、質量標準以及在其地域分散的人口中公平地獲得腎臟護理服務。墨西哥和巴西是拉丁美洲的主要需求中心，但公共採購、私人透析網路和專科分銷方面的不平衡影響了腎臟醫療設備的普及。在歐洲，英國、德國、法國、義大利和西班牙人口老化，但腎臟醫療保健服務成熟，腎臟登記和報銷監管體系完善，對血液透析系統、腹膜透析機、連續性腎臟替代療法（CRRT）平台、血管通路產品和腎結石治療技術的需求強勁。

為腎臟醫療設備業的領導者提供的實用建議

產業領導企業應優先考慮經過臨床檢驗、互通性且以服務為導向的腎臟醫療設備。這些器械能夠改善治療效果，同時降低整體醫療成本。隨著醫療系統應對慢性腎臟病的高發生率、急性腎損傷的風險以及醫療資源緊張等問題，居家血液透析、腹膜透析、互聯監測、更安全的血管通路、連續性腎臟替代療法（CRRT）、腎結石管理以及節水型透析基礎設施尤為重要。

腎臟疾病醫療設備的調查方法

本執行摘要基於系統性的研究途徑，結合了二手資料、監管資訊、臨床指南審查和市場檢驗。主要參考文獻包括世界衛生組織 (WHO)、美國疾病管制與預防中心 (CDC)、美國腎臟資料庫、歐洲監管指南、公共採購資訊、同儕審查的腎臟科文獻、衛生技術評估 (FDA) 資料庫、歐洲監管指南、公共採購資訊、同儕審查的腎臟科文獻、衛生技術評估 (HTA)資訊來源以及公開的醫療保健基礎設施。

結論：腎臟疾病治療醫療設備的策略性展望

隨著慢性腎臟病、糖尿病、高血壓、腎結石和急性腎損傷等疾病持續對醫療系統造成壓力，用於治療腎臟病的醫療設備正處於關鍵時刻。這種應用擴展不僅關乎提升醫療能力，更與早期診斷、居家透析、數位化連接、耐用耗材、病人安全、節水基礎設施以及基於實證醫學的報銷機制密切相關。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：腎臟病治療醫療設備市場：依產品類型分類

  • 配件
    • 採血管套裝
    • 透析濃縮液
    • 過濾器和薄膜
  • 導管
    • 腹膜透析導管
    • 血管通路導管
  • 用於連續性腎臟替代療法的醫療設備
  • 透析器
    • 高通量透析器
    • 低通量透析器
    • 超低通量透析器
  • 血液透析機
    • 家用血液透析機
    • 攜帶式血液透析機
    • 固定式血液透析機
  • 腹膜透析系統

第8章：腎臟疾病治療醫療設備市場：依治療方式分類

  • 持續腎臟替代療法
    • 連續性靜脈血液透析濾過
    • 持續性靜脈血液透析
    • 連續性靜脈血過濾
  • 血液透析
    • 居家血液透析
    • 院內血液透析
  • 腹膜透析
    • 自動化腹膜透析
    • 持續性門診腹膜透析

第9章：腎臟疾病治療醫療設備市場：依應用領域分類

  • 慢性腎臟病（CKD）
  • 急性腎損傷（AKI）
  • 末期腎病（ESRD）
  • 腎結石/尿道結石
  • 高血壓和體液代謝紊亂

第10章：腎臟疾病治療醫療設備市場：依最終用戶分類

  • 門診手術中心
  • 居家醫療
  • 醫院
  • 獨立透析中心

第11章：腎臟疾病治療醫療設備市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章：腎臟疾病治療醫療設備市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：腎臟疾病治療醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cantel Medical Corporation
  • Coloplast A/S
  • ConvaTec Group Plc
  • Cook Medical Inc.
  • Dialife SA
  • Dornier MedTech GmbH
  • Fresenius Medical Care AG & Co. KGaA
  • Hollister Incorporated
  • Infomed SA
  • JMS Co., Ltd.
  • Mediana Co., Ltd.
  • Medionics International
  • Medtronic plc
  • Nanodialysis BV
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • NxStage Medical, Inc.
  • Olympus Corporation
  • Outset Medical, Inc.
  • Quanta Dialysis Technologies Ltd.
  • Rockwell Medical, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • Toray Medical Co., Ltd.
  • WEGO Group
Product Code: MRR-030226489D4A

The Nephrology Devices Market is projected to grow by USD 21.94 billion at a CAGR of 6.50% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 14.11 billion
Estimated Year [2026] USD 15.00 billion
Forecast Year [2032] USD 21.94 billion
CAGR (%) 6.50%

Nephrology Devices Executive Summary

Nephrology devices are becoming a core pillar of chronic kidney disease, acute kidney injury, dialysis, kidney stone, and renal replacement therapy management. The need is structural: peer-reviewed estimates place global chronic kidney disease prevalence above 800 million people, while WHO data identify diabetes and hypertension as major upstream drivers of kidney failure risk.

Demand is concentrated around hemodialysis systems, peritoneal dialysis devices, dialyzers, bloodline sets, vascular access products, continuous renal replacement therapy platforms, water treatment systems, lithotripsy equipment, and remote monitoring tools. For executives, the nephrology devices landscape is defined by clinical reliability, reimbursement access, home-care enablement, infection control, fluid management, and data connectivity rather than device volume alone.

Transformative Shifts in the Nephrology Devices Landscape

The nephrology devices landscape is shifting from clinic-centered dialysis capacity toward earlier intervention, home-based renal care, and digitally connected treatment models. Kidney Disease: Improving Global Outcomes guidance continues to emphasize risk stratification, albuminuria testing, blood pressure control, diabetes management, and patient-centered modality choice, increasing demand for devices that support longitudinal kidney care.

Manufacturers are also navigating stricter quality expectations, supply chain scrutiny, and sustainability requirements. Dialysis is water- and energy-intensive, making efficient water treatment, low-waste consumables, durable machines, biocompatible dialyzers, safer vascular access solutions, and reliable home dialysis platforms increasingly important differentiators for hospitals, dialysis providers, and procurement agencies.

Cumulative Impact of Artificial Intelligence in Nephrology Devices

Artificial intelligence is having a cumulative impact across nephrology devices by improving patient monitoring, treatment planning, predictive maintenance, and clinical workflow. FDA and other regulators maintain active oversight pathways for AI-enabled medical technologies, while health systems are using validated analytics to identify acute kidney injury risk, flag dialysis complications, and support care coordination.

The strongest near-term value is not autonomous treatment but augmented decision support. AI can help detect vascular access dysfunction, optimize ultrafiltration alerts, analyze home dialysis adherence signals, support anemia and fluid-status management, and reduce avoidable downtime in dialysis machines when paired with quality data, clinician governance, cybersecurity controls, and post-market performance monitoring.

Key Regional Insights Across Global Nephrology Device Markets

Asia-Pacific is expanding its nephrology device adoption because China, India, Japan, South Korea, and Australia combine high diabetes prevalence, aging populations, and rising dialysis infrastructure. Japan and South Korea have mature dialysis quality systems, while China and India are scaling hospital capacity, public coverage, and local device production. Australia supports remote kidney care and home dialysis models, making connected monitoring and service reliability important.

North America remains highly advanced, supported by the United States Medicare ESRD program, strong home dialysis policy focus, national kidney disease surveillance, and established device approval pathways, while Canada emphasizes provincial quality standards and equitable access. Latin America, led by Brazil and Mexico, shows resilient demand for dialysis and renal care devices but faces uneven reimbursement, nephrologist availability, and infrastructure access across public and private systems.

Europe benefits from mature renal registries, procurement discipline, health technology assessment, and strong clinical adoption of high-quality dialysis, CRRT, vascular access, and urology devices. The Middle East is investing in tertiary hospitals and public-private specialty care, with GCC countries leading renal service capacity and imported advanced device use. Africa has significant unmet need, where affordability, consumable availability, water quality, electricity reliability, and workforce training determine access to renal replacement therapy.

Key Group Insights for ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN demand is shaped by expanding universal health coverage initiatives, urban dialysis networks, and a rising diabetes burden, particularly in Indonesia, Thailand, Malaysia, Vietnam, and the Philippines. The region requires cost-effective hemodialysis equipment, consumable reliability, training, and scalable peritoneal dialysis options to improve access beyond major cities. The GCC is prioritizing advanced hospital infrastructure, imported specialty devices, local renal care capacity, and public-private delivery models to reduce outbound treatment dependence.

The European Union emphasizes device safety, clinical evidence, Medical Device Regulation compliance, sustainability, and value-based procurement, creating demand for proven nephrology devices with strong post-market surveillance. BRICS countries represent scale, domestic manufacturing ambition, and wide access gaps, making pricing strategy, localization, and public-sector partnerships essential. G7 markets remain benchmarks for clinical adoption, reimbursement complexity, digital health integration, and premium innovation. NATO countries overlap with major procurement, resilience, and cybersecurity priorities, making secure connected devices and protected supply chains increasingly relevant for nephrology technology vendors.

Key Country Insights for Leading Nephrology Device Markets

The United States leads in dialysis spending, regulatory transparency, national ESRD data infrastructure, and home-care policy momentum, while Canada emphasizes provincial reimbursement, quality standards, and equitable renal access across geographically dispersed populations. Mexico and Brazil are important Latin American demand centers where public procurement, private dialysis networks, and uneven specialist distribution influence nephrology device adoption. In Europe, the United Kingdom, Germany, France, Italy, and Spain combine aging populations with mature nephrology services, renal registries, reimbursement oversight, and strong demand for hemodialysis systems, peritoneal dialysis devices, CRRT platforms, vascular access products, and kidney stone treatment technologies.

Russia requires localized distribution, regulatory navigation, service infrastructure, and reliable consumable supply to support renal replacement therapy delivery. China and India are scale markets driven by diabetes, hypertension, urban hospital growth, public insurance expansion, and increasing domestic manufacturing capacity. Japan has one of the world's most mature dialysis populations and strong quality expectations for safety, infection control, and treatment consistency. Australia supports home dialysis and remote care models for dispersed populations, while South Korea combines advanced hospitals, technology adoption, national insurance coverage, and a high standard of renal care delivery.

Actionable Recommendations for Nephrology Device Leaders

Industry leaders should prioritize clinically validated, interoperable, and service-backed nephrology devices that improve outcomes while lowering total cost of care. Home hemodialysis, peritoneal dialysis, connected monitoring, safer vascular access, CRRT, kidney stone management, and water-efficient dialysis infrastructure are especially important as health systems manage chronic kidney disease prevalence, acute kidney injury risk, and capacity constraints.

Commercial strategy should align with reimbursement evidence, local service networks, clinician training, patient education, spare-parts availability, and consumable reliability. Manufacturers should invest in cybersecurity, post-market surveillance, predictive maintenance, AI governance, infection prevention, and sustainability while building partnerships with dialysis providers, hospitals, nephrologists, payers, procurement agencies, and public health authorities to support scalable adoption.

Research Methodology for Nephrology Devices Intelligence

This executive summary is built on a structured research approach combining secondary evidence, regulatory intelligence, clinical guideline review, and market validation. Core references include WHO, CDC, USRDS, KDIGO, national renal registries, FDA databases, European regulatory guidance, public procurement information, peer-reviewed nephrology literature, health technology assessment sources, and publicly available healthcare infrastructure indicators.

Insights are triangulated across disease burden, dialysis and renal replacement therapy utilization indicators, reimbursement systems, device approval activity, hospital infrastructure, supply chain patterns, clinical standards, and expert interpretation. The methodology avoids unsupported market-size claims and emphasizes verified indicators that affect demand, adoption, compliance, safety, and strategic positioning in nephrology devices.

Conclusion: Strategic Outlook for Nephrology Devices

Nephrology devices are entering a decisive phase as chronic kidney disease, diabetes, hypertension, kidney stones, and acute kidney injury place sustained pressure on health systems. Growth in adoption is increasingly linked to earlier diagnosis, home dialysis, digital connectivity, resilient consumables, patient safety, water-efficient infrastructure, and evidence-based reimbursement rather than capacity expansion alone.

The strongest performers will combine device reliability with clinical data, service capability, affordability, cybersecurity, and regulatory discipline. Across developed and emerging markets, the clearest opportunities will come from technologies that improve access to renal care while reducing complications, operational burden, infection risk, and long-term treatment costs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Nephrology Devices Market, by Product Type

  • 7.1. Accessories
    • 7.1.1. Blood Tubing Sets
    • 7.1.2. Dialysate Concentrates
    • 7.1.3. Filters And Membranes
  • 7.2. Catheters
    • 7.2.1. Peritoneal Dialysis Catheters
    • 7.2.2. Vascular Access Catheters
  • 7.3. Continuous Renal Replacement Therapy Devices
  • 7.4. Dialyzers
    • 7.4.1. High Flux Dialyzers
    • 7.4.2. Low Flux Dialyzers
    • 7.4.3. Ultra Low Flux Dialyzers
  • 7.5. Hemodialysis Machines
    • 7.5.1. Home Hemodialysis Machine
    • 7.5.2. Portable Hemodialysis Device
    • 7.5.3. Stationary Hemodialysis Machine
  • 7.6. Peritoneal Dialysis Systems

8. Nephrology Devices Market, by Modality

  • 8.1. Continuous Renal Replacement Therapy
    • 8.1.1. Continuous Venovenous Hemodiafiltration
    • 8.1.2. Continuous Venovenous Hemodialysis
    • 8.1.3. Continuous Venovenous Hemofiltration
  • 8.2. Hemodialysis
    • 8.2.1. Home Hemodialysis
    • 8.2.2. In Center Hemodialysis
  • 8.3. Peritoneal Dialysis
    • 8.3.1. Automated Peritoneal Dialysis
    • 8.3.2. Continuous Ambulatory Peritoneal Dialysis

9. Nephrology Devices Market, by Application

  • 9.1. Chronic Kidney Disease (CKD)
  • 9.2. Acute Kidney Injury (AKI)
  • 9.3. End-Stage Renal Disease (ESRD)
  • 9.4. Kidney Stones / Urolithiasis
  • 9.5. Hypertension & Fluid Disorders

10. Nephrology Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Home Care Settings
  • 10.3. Hospitals
  • 10.4. Standalone Dialysis Centers

11. Nephrology Devices Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Nephrology Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Nephrology Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Concentration Analysis, 2025
    • 14.1.1. Concentration Ratio (CR)
    • 14.1.2. Herfindahl Hirschman Index (HHI)
  • 14.2. Recent Developments & Impact Analysis, 2025
  • 14.3. Product Portfolio Analysis, 2025
  • 14.4. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Asahi Kasei Corporation
  • 15.2. B. Braun Melsungen AG
  • 15.3. Baxter International Inc.
  • 15.4. Becton, Dickinson and Company
  • 15.5. Boston Scientific Corporation
  • 15.6. Cantel Medical Corporation
  • 15.7. Coloplast A/S
  • 15.8. ConvaTec Group Plc
  • 15.9. Cook Medical Inc.
  • 15.10. Dialife SA
  • 15.11. Dornier MedTech GmbH
  • 15.12. Fresenius Medical Care AG & Co. KGaA
  • 15.13. Hollister Incorporated
  • 15.14. Infomed SA
  • 15.15. JMS Co., Ltd.
  • 15.16. Mediana Co., Ltd.
  • 15.17. Medionics International
  • 15.18. Medtronic plc
  • 15.19. Nanodialysis B.V.
  • 15.20. Nikkiso Co., Ltd.
  • 15.21. Nipro Corporation
  • 15.22. NxStage Medical, Inc.
  • 15.23. Olympus Corporation
  • 15.24. Outset Medical, Inc.
  • 15.25. Quanta Dialysis Technologies Ltd.
  • 15.26. Rockwell Medical, Inc.
  • 15.27. Teleflex Incorporated
  • 15.28. Terumo Corporation
  • 15.29. Toray Medical Co., Ltd.
  • 15.30. WEGO Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEPHROLOGY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL NEPHROLOGY DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL NEPHROLOGY DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL NEPHROLOGY DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEPHROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL NEPHROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ACCESSORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ACCESSORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD TUBING SETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD TUBING SETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD TUBING SETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DIALYSATE CONCENTRATES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DIALYSATE CONCENTRATES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DIALYSATE CONCENTRATES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FILTERS AND MEMBRANES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FILTERS AND MEMBRANES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FILTERS AND MEMBRANES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERITONEAL DIALYSIS CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERITONEAL DIALYSIS CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERITONEAL DIALYSIS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VASCULAR ACCESS CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VASCULAR ACCESS CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VASCULAR ACCESS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DIALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DIALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HIGH FLUX DIALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HIGH FLUX DIALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HIGH FLUX DIALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LOW FLUX DIALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LOW FLUX DIALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LOW FLUX DIALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ULTRA LOW FLUX DIALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ULTRA LOW FLUX DIALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ULTRA LOW FLUX DIALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HEMODIALYSIS MACHINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HEMODIALYSIS MACHINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HEMODIALYSIS MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HOME HEMODIALYSIS MACHINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HOME HEMODIALYSIS MACHINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HOME HEMODIALYSIS MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PORTABLE HEMODIALYSIS DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PORTABLE HEMODIALYSIS DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PORTABLE HEMODIALYSIS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL STATIONARY HEMODIALYSIS MACHINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL STATIONARY HEMODIALYSIS MACHINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL STATIONARY HEMODIALYSIS MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERITONEAL DIALYSIS SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERITONEAL DIALYSIS SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERITONEAL DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CONTINUOUS VENOVENOUS HEMODIAFILTRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CONTINUOUS VENOVENOUS HEMODIAFILTRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CONTINUOUS VENOVENOUS HEMODIAFILTRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CONTINUOUS VENOVENOUS HEMODIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CONTINUOUS VENOVENOUS HEMODIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CONTINUOUS VENOVENOUS HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CONTINUOUS VENOVENOUS HEMOFILTRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CONTINUOUS VENOVENOUS HEMOFILTRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CONTINUOUS VENOVENOUS HEMOFILTRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HEMODIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HEMODIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HOME HEMODIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HOME HEMODIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HOME HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL IN CENTER HEMODIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL IN CENTER HEMODIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL IN CENTER HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AUTOMATED PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AUTOMATED PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AUTOMATED PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CONTINUOUS AMBULATORY PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CONTINUOUS AMBULATORY PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CONTINUOUS AMBULATORY PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CHRONIC KIDNEY DISEASE (CKD) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CHRONIC KIDNEY DISEASE (CKD) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CHRONIC KIDNEY DISEASE (CKD) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ACUTE KIDNEY INJURY (AKI) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ACUTE KIDNEY INJURY (AKI) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ACUTE KIDNEY INJURY (AKI) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL END-STAGE RENAL DISEASE (ESRD) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL END-STAGE RENAL DISEASE (ESRD) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL END-STAGE RENAL DISEASE (ESRD) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL KIDNEY STONES / UROLITHIASIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL KIDNEY STONES / UROLITHIASIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL KIDNEY STONES / UROLITHIASIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL HYPERTENSION & FLUID DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL HYPERTENSION & FLUID DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HYPERTENSION & FLUID DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL STANDALONE DIALYSIS CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL STANDALONE DIALYSIS CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL STANDALONE DIALYSIS CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. GCC NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 201. GCC NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. GCC NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 203. GCC NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 204. GCC NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 205. GCC NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 206. GCC NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 207. GCC NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 208. GCC NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 209. GCC NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 210. GCC NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. GCC NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. G7 NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. G7 NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. G7 NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 239. G7 NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 240. G7 NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 241. G7 NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 242. G7 NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 243. G7 NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 244. G7 NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 245. G7 NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 246. G7 NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. G7 NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. NATO NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 249. NATO NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. NATO NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 251. NATO NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 252. NATO NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 253. NATO NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 254. NATO NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 255. NATO NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 256. NATO NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 257. NATO NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 258. NATO NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. NATO NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. CANADA NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. CANADA NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. CANADA NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 276. CANADA NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 277. CANADA NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 278. CANADA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 279. CANADA NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 280. CANADA NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 281. CANADA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 282. CANADA NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 283. CANADA NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. CANADA NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. MEXICO NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 286. MEXICO NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. MEXICO NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 288. MEXICO NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 289. MEXICO NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 290. MEXICO NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 291. MEXICO NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 292. MEXICO NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 293. MEXICO NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 294. MEXICO NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 295. MEXICO NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 296. MEXICO NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. BRAZIL NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 298. BRAZIL NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. BRAZIL NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 300. BRAZIL NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 301. BRAZIL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 302. BRAZIL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 303. BRAZIL NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 304. BRAZIL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 305. BRAZIL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 306. BRAZIL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 307. BRAZIL NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 308. BRAZIL NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED KINGDOM NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED KINGDOM NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED KINGDOM NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED KINGDOM NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED KINGDOM NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED KINGDOM NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED KINGDOM NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED KINGDOM NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED KINGDOM NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED KINGDOM NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED KINGDOM NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED KINGDOM NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 321. GERMANY NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 322. GERMANY NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 323. GERMANY NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 324. GERMANY NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 325. GERMANY NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 326. GERMANY NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 327. GERMANY NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 328. GERMANY NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 329. GERMANY NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 330. GERMANY NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 331. GERMANY NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 332. GERMANY NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 333. FRANCE NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 334. FRANCE NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 335. FRANCE NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 336. FRANCE NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 337. FRANCE NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 338. FRANCE NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 339. FRANCE NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 340. FRANCE NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 341. FRANCE NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 342. FRANCE NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 343. FRANCE NEPHROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 344. FRANCE NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 345. RUSSIA NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 346. RUSSIA NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 347. RUSSIA NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 348. RUSSIA NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 349. RUSSIA NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 350. RUSSIA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 351. RUSSIA NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 352. RUSSIA NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 353. RUSSIA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 354. RUSSIA NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 355. RUSSIA NEPHROLOGY DEVI